14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $19.44 $26.68 Friday, 3rd May 2024 SAVA stock ended at $22.05. This is 0.0453% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.68% from a day low at $21.99 to a day high of $22.36.
90 days $18.18 $26.68
52 weeks $12.32 $32.10

Historical Cassava Sciences Inc. prices

Date Open High Low Close Volume
May 03, 2024 $22.15 $22.36 $21.99 $22.05 1 137 657
May 02, 2024 $22.20 $22.25 $21.89 $22.06 1 044 308
May 01, 2024 $22.11 $22.26 $21.91 $22.14 951 804
Apr 30, 2024 $22.02 $22.40 $22.02 $22.15 792 005
Apr 29, 2024 $22.33 $22.50 $21.95 $22.30 851 937
Apr 26, 2024 $22.00 $22.45 $21.70 $22.34 1 061 170
Apr 25, 2024 $20.58 $21.85 $20.43 $21.73 894 551
Apr 24, 2024 $20.68 $20.84 $20.17 $20.74 476 338
Apr 23, 2024 $20.65 $21.21 $20.35 $20.55 497 635
Apr 22, 2024 $19.80 $20.82 $19.74 $20.50 755 038
Apr 19, 2024 $21.01 $21.20 $19.47 $19.64 1 310 902
Apr 18, 2024 $21.23 $21.94 $20.78 $21.19 960 338
Apr 17, 2024 $21.03 $21.59 $20.76 $21.27 633 772
Apr 16, 2024 $19.97 $21.74 $19.44 $21.03 1 240 778
Apr 15, 2024 $22.78 $22.89 $19.61 $20.01 2 089 481
Apr 12, 2024 $26.08 $26.44 $22.50 $22.75 1 875 649
Apr 11, 2024 $24.61 $26.68 $24.30 $26.11 1 812 985
Apr 10, 2024 $24.41 $25.36 $24.06 $24.51 995 632
Apr 09, 2024 $24.00 $25.59 $23.06 $25.40 1 840 320
Apr 08, 2024 $21.33 $24.12 $21.19 $23.57 1 280 418
Apr 05, 2024 $20.75 $21.44 $20.44 $21.31 548 331
Apr 04, 2024 $20.87 $20.99 $20.22 $20.48 674 412
Apr 03, 2024 $19.72 $20.62 $19.55 $20.58 604 589
Apr 02, 2024 $19.90 $20.03 $19.46 $19.71 625 181
Apr 01, 2024 $20.26 $20.89 $19.98 $20.29 429 362
Click to get the best stock tips daily for free!

About Cassava Sciences Inc.

Cassava Sciences Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci... SAVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT